Jamp-Metformin Product Recall (2020-03-10)
- Starting date:
- March 10, 2020
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-72565
Last updated: 2020-03-12
Summary
-
Product:
A. Jamp-Metformin 500 mg tabletB. Jamp-Metformin 850 mg tablet
A. Jamp-Metformin 500 mg tablet
B. Jamp-Metformin 850 mg tablet
Reason
Affected lots may contain N-nitrosodimethylamine (NDMA) above the interim acceptable concentration limit.
Depth of distribution
Retailers
Affected products
A. Jamp-Metformin 500 mg tablet
DIN, NPN, DIN-HIM
DIN 02380196
Dosage form
tablet
Strength
Metformin hydrochloride 500 mg
Lot or serial number
X20283, X20284, X20286, X20287, X20288, Y00225, Y00226, Y00227, Y00228, Y00229, Y00230, Y00231, Y00232, Y01573, Y01574, Y01575, Y01576, Y01577, Y01578, Y01579, Y01580
Companies
- Recalling Firm
-
JAMP Pharma Corporation
1310 Nobel Street
Boucherville
J4B 5H3
Quebec
CANADA
- Marketing Authorization Holder
-
JAMP Pharma Corporation
1310 Nobel Street
Boucherville
J4B 5H3
Quebec
CANADA
B. Jamp-Metformin 850 mg tablet
DIN, NPN, DIN-HIM
DIN 02380218
Dosage form
tablet
Strength
Metformin hydrochloride 850 mg
Lot or serial number
X20385, X20386, X19224, X19225, X19226
Companies
- Recalling Firm
-
JAMP Pharma Corporation
1310 Nobel Street
Boucherville
J4B 5H3
Quebec
CANADA
- Marketing Authorization Holder
-
JAMP Pharma Corporation
1310 Nobel Street
Boucherville
J4B 5H3
Quebec
CANADA